Avanir
This article was originally published in The Tan Sheet
Executive Summary
Company is relocating its corporate headquarters and commercial development operations to a larger facility in San Diego. The new headquarters covers approximately 27,000 sq. ft. of biology, chemical and other lab facilities and office space. In July, Avanir's Abreva cream was approved by the FDA as an OTC treatment for cold sores and fever blisters; SmithKline Beecham is marketing the product (1"The Tan Sheet" July 31, p. 3)
You may also be interested in...
Avanir Abreva Cold Sore/Fever Blister Cream Approved By FDA
Avanir Pharmaceuticals' 10% docosanol cream was approved July 25 for the treatment of cold sores and fever blisters. The product, which FDA's approval letter indicates will be marketed as Abreva Cream, will be the first FDA-approved OTC cold sore and fever blister treatment.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands